Status:
COMPLETED
Myocardial Bridging in Obstructive Hypertrophic Cardiomyopathy
Lead Sponsor:
Chinese Academy of Medical Sciences, Fuwai Hospital
Conditions:
Myocardial Bridging
Obstructive Hypertrophic Cardiomyopathy
Eligibility:
All Genders
18+ years
Brief Summary
This study investigated the impact of myocardial bridging (MB) and its characteristics on preoperative atrial fibrillation and survival in patients with obstructive hypertrophic cardiomyopathy (oHCM)....
Eligibility Criteria
Inclusion
- I(i) age ≥ 18 years and (ii) diagnosis of oHCM based on clinical and echocardiographic evaluation.
- \-
Exclusion
- (i) a history of heart surgery (ii) Patients who had coronary atherosclerosis or myocardial infraction; (iii) Patients who had no angiography records.
- \-
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
968 Patients enrolled
Trial Details
Trial ID
NCT06598995
Start Date
January 1 2022
End Date
December 31 2022
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fuwai Hospital
Beijing, Please Select, China, 475